MSLN and pancreatic ductal adenocarcinoma: The results reported by Yen et al. are not in accordance with those of other studies, in which a high expression level of MSLN has been associated with poor survival in other malignant epithelial neoplasms, such as lung adenocarcinomas and pancreatic ductal adenocarcinomas [40,41].